Clinical Trial Update: Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating the safety and feasibility of treating pediatric bronchiolitis obliterans with airway basal stem cells. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans

Drugs mentioned

• Airway Basal Stem Cells

Snippet

Sponsor: Regend Therapeutics | Conditions: Pediatric Bronchiolitis Obliterans | EARLY_Phase 1 | Status: RECRUITING